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ABSTRACT
Background: Problem gambling is a serious public
health concern at an international level where
population prevalence rates average 2% or more and
occurs more frequently in younger populations. The
most empirically established treatments until now are
combinations of cognitive and behavioural techniques
labelled cognitive behaviour therapy (CBT). However,
there is a paucity of high quality evidence for the
comparative efficacy of core CBT interventions in
treating problem gamblers. This study aims to isolate
and compare cognitive and behavioural (exposure-
based) techniques to determine their relative efficacy.
Methods: A sample of 130 treatment-seeking problem
gamblers will be allocated to either cognitive or
exposure therapy in a two-group randomised, parallel
design. Repeated measures will be conducted at
baseline, mid and end of treatment (12 sessions
intervention period), and at 3, 6 and 12 months
(maintenance effects). The primary outcome measure
is improvement in problem gambling severity
symptoms using the Victorian Gambling Screen (VGS)
harm to self-subscale. VGS measures gambling
severity on an extensive continuum, thereby enhancing
sensitivity to change within and between individuals
over time.
Discussion: This article describes the research
methods, treatments and outcome measures used to
evaluate gambling behaviours, problems caused by
gambling and mechanisms of change. This study will
be the first randomised, parallel trial to compare
cognitive and exposure therapies in this population.
Ethics and dissemination: The study was approved
by the Southern Adelaide Health Service/Flinders
University Human Research Ethics Committee. Study
findings will be disseminated through peer-reviewed
publications and conference presentations.
Trial registration: Australian New Zealand Clinical
Trials Registry: ACTRN 12610000828022.
INTRODUCTION
Pathological gambling (PG) from a mental
health perspective is deﬁned by the American
Psychiatric Association DSM-IV-TR as ‘…per-
sistent and recurrent maladaptive gambling
behaviour that disrupts personal, family and
vocational pursuits’.1 The term ‘problem gam-
bling’ deﬁnes less severe forms of gambling
disorders and has been the basis for the devel-
opment of several diagnostic and screening
ARTICLE SUMMARY
Article focus
▪ To isolate and compare cognitive and behavioural
(exposure-based) techniques to determine their
relative efficacy in treating problem gambling.
▪ The primary research question is: among
treatment-seeking problem gamblers, is exposure
therapy more effective in reducing gambling
severity symptoms (harm to self-subscale of
VGS) over the 15-month study period (interven-
tion and maintenance effects) compared with
cognitive therapy?
Key messages
▪ Problem gambling is a serious public health
concern at an international level and occurs
more frequently in younger populations.
▪ The best evidence for gambling treatments is for
cognitive behavioural therapy but remains tentative.
▪ This study will be the first randomised, parallel
trial to compare cognitive and exposure therapies
in this population.
Strengths and limitations of this study
▪ A key strength of this study is that all treatment-
seeking problem gamblers meeting eligibility cri-
teria will receive active treatment. Also, owing to
the broad study inclusion criteria, it is expected
that a significant proportion of the sample will
have comorbid conditions (eg, anxiety, depres-
sion and substance abuse which will enhance
the external validity of findings using an
intent-to-treat design.
▪ A limitation of the design is that there was no
control group to account for non-specific treatment
effects; however, a reasonable assumption is made
that non-specific effects will be approximately
similar between study groups due to the analo-
gous therapy structures, therapist background and
experience and therapeutic environment.
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instruments such as the Canadian Problem Gambling
Index (CGPI)2 and the Victorian Gambling Screen
(VGS).3 It is a serious public health concern at an inter-
national level where population prevalence rates average
2% or more and occurs more frequently in younger popu-
lations.4–9 Comorbid mental health disorders such as
depression and anxiety are common in both treatment-
seeking and general populations of problem gamblers.10
Treatment types available for gambling disorders have
similarities to those of other addictions and include psy-
chological, peer-support and, more recently, pharmaco-
logical interventions.11 12 Until now, the best evidence
for gambling treatments is psychological, where cogni-
tive behavioural therapy (CBT) has been the most
researched13 and the evidence-base recommended as
‘…trusted to guide practice in most situations’ based on
the National Health and Medical Research Council
grades for developers of guidelines.14
The theoretical underpinnings of CBT include cogni-
tions (eg, erroneous thoughts) and psychobiological
states (eg, physiological arousal) and are two dominant
approaches to explaining gambling disorders.15 Most
variants of CBT for treating gambling disorders have
shown to be clinically beneﬁcial compared with no treat-
ment, and the most rigorous clinical trials have com-
prised a combined cognitive-behavioural approach.13 16
For core techniques, ﬁndings have indicated that cogni-
tive therapy (CT) has an ‘added advantage’ when com-
pared directly with no treatment, although evidence is
tentative due to the heterogeneity between studies.13
Cognitive restructuring plays an important role in CT
and has been shown to be beneﬁcial in treating a range
of mental health conditions.17
However, the comparative efﬁcacy of CT with other
core CBT interventions such as behavioural (exposure-
based) therapies that target psychobiological-related
gambling pathology is unknown.13 Exposure therapy
(ET) is grounded in classical and operant conditioning
paradigms and, where cue-exposure with extinction pro-
cesses has been proposed as more beneﬁcial than other
types (eg, aversive therapy), in treating gambling addic-
tion.18 ET has been shown to be as effective as CT in
treating anxiety disorders where both techniques have
similar hypothesised mechanisms of therapeutic change
to those in gambling disorders.19 20 In addictions, there
is no conclusive evidence for exposure-based treatments
due to there being few clinical trials with power.21
As behavioural therapies in general are more parsimo-
nious in terms of delivery than CT,22 it is important
from a public-health point of view to understand the
relative efﬁcacy of these core treatments. Therefore, we
designed a study titled ‘Comparing outcomes of cogni-
tive and exposure therapy for problem gambling’, which
is a randomised trial comparing the efﬁcacies of CT and
ET. This trial is motivated by the uncertainty about the
clinical superiority of CT over ET. Based on this uncer-
tainty, the concept of equipoise exists and participants
will therefore not be disadvantaged from randomisation
to either treatment group. This study will be the ﬁrst to
compare these treatments in a population of treatment-
seeking gamblers.
Study design
Comparing the outcomes of cognitive and ET for gam-
bling disorders is a two-group randomised, parallel
design with treatment-seeking problem gamblers pre-
senting to the Statewide Gambling Therapy Service
(SGTS) in South Australia. The study will recruit 130
participants over a 12-month period starting April 2011.
The outpatient SGTS programme offers one-on-one and
group therapies for problem gamblers at three key
metropolitan (Adelaide) centres, one of which will be
selected as the trial site. The primary referral sources of
clients presenting to SGTS are self, Gambling Helpline
and related agencies and general practitioners. The
service is staffed by a psychiatrist and therapists with pro-
fessional registration in psychology, nursing or social
work. All therapists have graduate qualiﬁcations and clin-
ical experience in CBT.19 Data collection will ﬁnish in
July 2013.
The study was approved by the Southern Adelaide
Health Service/Flinders University Human Research
Ethics Committee and registered with the Australian New
Zealand Clinical Trials Registry (ACTRN12610000828022)
at the trials inception. The research ofﬁcer will give parti-
cipants an information statement regarding the study and
ask for written informed consent before data collection
begins.
Participant recruitment and random assignment
To assess study eligibility, an independent clinician will
conduct semistructured interviews with treatment-
seeking problem gamblers presenting to SGTS during
the recruitment period. The interview will include
assessment of individual demographics, recent gambling
activities and administration of the well-validated South
Oaks Gambling Screen (SOGS).23 SOGS is a 20-item ques-
tionnaire based on DSM criteria for PG. A score of 5 or
more is indicative of a probable pathological gambler. In
gambling treatment samples, the scale has good reliabil-
ity, exhibits high correlations with DSM-IV diagnostic cri-
teria, and good-to-excellent classiﬁcation accuracy.24
Study eligibility will be based on the following inclu-
sion criteria: 18 years of age or older; treatment seeking
for problem gambling with electronic gaming machines
(EGMs); not involved in a concurrent gambling treat-
ment programme; not received psychological treatment
for problem gambling in the previous 12 months; willing
to participate in the study; a willingness to read and
respond to self-rated questionnaires written in English;
willing to be randomised to one of two psychological
treatments; gambled in the past month using EGMs;
willing to provide follow-up data; willing to have treat-
ment sessions audio recorded; scoring 5 or greater on
SOGS and not suicidal or experiencing mental distress,
such as mania, which would indicate that the problem
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gambler would not be able to participate fully in the
treatment offered.
Individuals assessed as eligible for study participation
will be randomly assigned to one of two treatment
groups with a 1:1 allocation ratio. Randomisation will be
blocked to increase the likelihood of equal group sizes,
using a standard permutated block algorithm in which
block sizes will be randomly chosen from 2, 4 and 6 to
protect concealment. To ensure balance on potential
confounders, block randomisation within strata will be
used, stratifying at median age, gender and median
SOGS scores for problem gambling severity. Based on
previous SGTS data, age will be stratiﬁed as 18–42, and
43 years or more.25 Gambling severity will be stratiﬁed
according to previous treatment-seeking problem gam-
blers’ SOGS scores of either 5–11 or between 12 and
20.26 A statistician will independently generate random
sequences for each stratum using Stata V.11.1 software27
and deliver to the clinical trials call centre of a centrally
located hospital pharmacy. Staff enrolling and referring
participants, as well as those collecting and entering
data and administering interventions, will not know
in advance which treatment the next participant will
receive.
Sample size
The primary research question is: among treatment-
seeking problem gamblers, is ET more effective in redu-
cing gambling severity symptoms (harm to self-subscale
of the VGS) over the 12-month study period (interven-
tion and maintenance effects) compared with CT?
Based on a type I error rate of 5%, power of 90%, two-
tailed test, and a VGS SD of 10.2 units,25 to detect a sig-
niﬁcant difference of 8% (ie, 4.8 points on the scale) in
the mean VGS scores between the ET and CT groups,
50 participants will be required in each group. Given the
treatment dropout rate experienced in the SGTS treat-
ment programme (approximately 30%), we therefore
would need to recruit 65 participants in each group of
the study, giving a total sample size of 130 participants.
Therapists
CT will be provided by two psychotherapists with qualiﬁ-
cations in psychology and, on average, having approxi-
mately 5 years practice experience, including 2 years in
treating individuals with gambling disorders. The thera-
pists will receive initial on-site training in CT by Robert
Ladouceur, a widely published international clinician
and researcher in the ﬁeld of CT for gambling disor-
ders.28–30
ET will be provided by two psychotherapists with post-
graduate qualiﬁcations in CBT: a registered mental
health nurse and a psychology graduate. On average,
therapists have 6 years clinical experience in delivering
CBT treatments to clients of SGTS, including a manua-
lised ET programme. Therapists will receive on-site
supervision from Malcolm Battersby who trained at the
Institute of Psychiatry, London in behavioural treatments
of anxiety disorders and severe neurotic conditions and
is the Director of the Flinders Gambling Research
Centre and SGTS.19
Study treatments
The trial will comprise two interventions:CT and ET.
Participants in both groups will receive a standard of 12
60 min individual treatment sessions, ranging from 4 to
16, depending on co-occurring conditions, conducted at
weekly intervals. Both treatment manuals are intended
as a session-by-session guide for therapists treating indivi-
duals with a gambling disorder where EGMs are the
main form of gambling problem. The therapists will
deliver treatment according to the content of each
manual and sequencing of techniques in a face-to-face
format. A summary of treatment sessions is provided in
table 1.
Blinding
Statistical analyses will be conducted according to prespe-
ciﬁed guidelines. In this trial, therapists will know what
treatment they are administering and participants will be
provided with information that will rationalise and
describe their assigned therapy protocol. Participants will
be blinded to the study hypothesis in order to reduce the
likelihood for self-report bias. Participant information
sheets will refer to treatments as ‘well known and com-
monly used psychological treatments’.
Treatment integrity
All treatment sessions will be audio recorded and 20%
will be randomly selected from the early, mid and late
study phases and evaluated using a checklist based on
the CT Scale (table 2).31 ET sessions will be evaluated by
MB and RP who are senior consultant psychiatrists with
the Flinders Gambling Research Centre and have exten-
sive experience in treatments for gambling disorders
and other addictions19 32 CT sessions will be evaluated
by RL and MD who are senior clinical psychologists.
Measures
The administration of measures during the intervention
period will be conducted prior to the start of each treat-
ment session and at the 3-month and 6-month follow-up
visits with a study therapist. The 12-month follow-up
questionnaires will be mailed to participants. Baseline
assessment will include demographic variables and data
for the duration of the gambling problem. Validated
outcome measures will cover domains of gambling beha-
viours, problems caused by gambling, and mechanisms
of change.33 This means that, for ET participants, a
greater reduction in the urge to gamble is expected to
be associated with a clinically meaningful improvement
in treatment outcomes than for CT participants. For CT
participants, a more accurate set of beliefs relating to
gambling is expected to be associated with a clinically
meaningful improvement in treatment outcomes than
for ET participants. The measures are summarised in
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the following sections and the measurement occasions
are presented in table 3.
In order to detect changes in problem gambling sever-
ity during treatment and at follow-up, VGS will be uti-
lised as a primary outcome measure. VGS is a
self-reported questionnaire measuring the extent to
which gambling behaviour has impeded an individual’s
life. The screen comprises three subscales (enjoyment of
gambling, harm to partner and harm to self) with a
total of 21 items. In this study, the harm to self-subscale
will be used as the primary outcome measure. Items on
the self-harm subscale relate to the person’s experiences
in the previous 4 weeks and have been validated for use
in Australia in a clinical population of problem gam-
blers.34 Total scores for the 15 items range from 0=no
harm to self to 60=high harm to self and a score of 21+
identiﬁes a person as a problem gambler. Concurrent
validity indicates that the scale correlates very highly
with SOGS but extends the score range.
Secondary outcome measures will include DSM-IV-TR
diagnostic criteria relating to the extent of persistent and
recurrent maladaptive gambling behaviour and be
Table 1 Intervention schedule
Weekly
sessions Cognitive therapy (CT) Exposure therapy (ET)
Session 1 Pretreatment assessment to identify problem
gambling and any comorbid conditions. Rationale and
protocol of cognitive therapy explained
Pretreatment assessment to identify problem
gambling and any comorbid conditions. Rationale and
protocol of exposure therapy explained
Session 2 Development of participant’s measurable problems
and goals. Analysis of a gambling session to identify
erroneous thoughts. Start a daily self-monitoring diary
Development of participant’s measurable problems
and goals. Establish cash restrictions to ensure
participant has no cash. First exposure task set using
images. Start a daily self-monitoring diary
Session 3 Psychoeducation: clarification of the concept of
chance and establishing the distinction between
games of skill and games of chance
Review participant’s attempt at first exposure task.
Finalise cash restriction strategies if not already in
place. In-session imagery exposure task with
therapist guidance
Session 4 Psychoeducation/cognitive awareness: introduce
ABCD (situation, thoughts, behaviour, consequences)
model and exercises to focus on the gambling
thoughts or ‘inner dialogue’
Review imagery exposure task. Finalise cash
restriction strategies if not already in place. Imagery
exposure task with therapist guidance
Session 5 Identifying erroneous thoughts or ‘gambling traps’ that
lie behind emotions taking over reason using the
ABCD model. Participants are encouraged to
challenge these thoughts, perceptions and beliefs in
this session
Review imagery exposure task. Introduction of next
exposure task involving image and sounds of
gambling-related cues
Session 6 Identifying erroneous cognitions. Practical exercise to
help participant organise and act upon thoughts
Introduction to the first of the in vivo exposure tasks.
This task to take place outside the participant’s usual
gambling venue(s). The participant utilises principles
of exposure therapy from imaginal tasks to assist in
identifying what is happening to them at the time of
the in vivo task
Session 7 Identifying erroneous cognitions. Practical exercise to
help participant organise and act upon thoughts
(continued)
Fine-tuning of in vivo exposure task outside the
venue. Introduction to the in vivo exposure task to
take place inside the venue without cash
Session 8 Develop skills for challenging and casting doubt on
the erroneous thoughts that lead to excessive
gambling
Fine-tuning of in vivo exposure task inside the venue
without cash. Introduction to the next in vivo task
taking place inside a gambling venue with a small
amount of cash
Session 9 Develop skills for challenging and casting doubt on
the erroneous thoughts that lead to excessive
gambling (continued)
Fine-tuning of in vivo exposure task inside the venue
with a small amount of cash. Introduction to the next
in vivo task taking place inside a gambling venue
changing a small amount of cash for Poker machine
coins
Session 10 Develop skills for challenging and casting doubt on
the erroneous thoughts that lead to excessive
gambling (continued)
Review in vivo exposure tasks. Introduction to the
next in vivo task taking place inside a gambling
venue changing a small amount of cash for coins and
placing in the Poker machine
Sessions 11
and 12
Explore gambling relapse and develop relapse
prevention strategies
Explore gambling relapse and develop relapse
prevention strategies
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administered by study therapists. A total score is obtained
by summing across the 10 responses of ‘yes’ or ‘no’. A
score of 5 or more indicates PG.1 All other secondary
measures are self-reported. Gambling-related cognitions
will be measured using a 23-item scale (GRCS) that
records common thoughts associated with problem gam-
bling, where each item is rated on a 1–7 Likert scale.35
The urge to gamble will be assessed using a 6-item instru-
ment (GUS), where each item is rated on a 1–7 Likert
scale.36 37 Participants’ experiences of psychological dis-
tress will be recorded using a 10-item global measure
(K10), with each item rated on a 1–5 Likert scale.38 To
measure an individual’s perspective of their functional
ability/impairment relating to work and social activities, a
5-item scale (WSAS) will be used where each item is rated
on a 0–8 Likert scale.39 Participant levels of alcohol use
will be assessed based on a 10-item scale where questions
1–3 measure the quantity and frequency of alcohol use,
questions 4–6 measure the possible dependence on
alcohol and questions 7–10 measure alcohol-related
problems.40
Following an explanation of treatment rationale and
protocol in session one, participants will be asked to rate
their conﬁdence in treatment (from 0=extremely unconﬁ-
dent to 6=extremely conﬁdent) and belief in treatment
logical (from 0=extremely illogical to 6=extremely logical) at
the start of session two. At treatment completion, partici-
pants will be asked to rate their level of satisfaction with
the treatment received (from 0=extremely unsatisﬁed to
6=extremely satisﬁed). To assess a participant’s degree of
conﬁdence in their perceived ability to execute control
of gambling behaviours during treatment and follow-up,
a measure of self-efﬁcacy will be utilised. Participants will
describe up to three personally relevant high-risk situa-
tions and then rate the extent of their belief that they
could refrain from gambling excessively in these situa-
tions on a scale of 0–10. Self-reported measures of beha-
viours relating to problematic gambling will include:
frequency of gambling in the previous month; number
of hours spent on gambling activities in the previous
month and amount spent on gambling activities in the
previous month.
Follow-up
High rates of treatment and follow-up attrition occur for
problem gamblers.41 To improve completion rates of
self-rated questionnaires at follow-up for both treatment
completers and treatment drop-outs, study participants
will be offered honorarium gift vouchers to the value of
$10 at treatment completion; $20 at 3-month follow-up;
Table 2 Treatment integrity checklist items
Item
Response
options Cognitive therapy Exposure therapy
1 Yes/no/or N/A
(not applicable)
Eliciting automatic thoughts: gambling related Cash management: effective plan established
and agreed by the client
2 Yes/no/or N/A Case conceptualisation: linking beliefs and
thoughts with behaviour, eliciting feedback from
client regarding validity and usefulness
Case conceptualisation: linking autonomic
responses with behaviour, eliciting feedback
from client regarding validity and usefulness
3 Yes/no/or N/A Sharing conceptualisation with client: used
meaningful examples
Sharing conceptualisation with client: used
meaningful examples
4 Yes/no/or N/A Eliciting core beliefs/schemata: gambling related Eliciting autonomic symptoms, thoughts, and
behaviours: gambling related
5 Yes/no/or N/A Addressing key issues: raised key issues and
related them to cognition and behaviour
Setting and conduct of exposure tasks:
appropriately graded, focused, prolonged and
repeated; agreed by the client; relevant to
therapy goals
6 Yes/no/or N/A Guided discovery: Socratic questioning,
reflective/confronting (eg, what would that
mean?)/interpretive responses to guide client’s
understanding
Addressing key issues: raised key issues and
related them to urge and behaviour
7 Yes/no/or N/A Asking for alternative thoughts: alternative views/
explanations appropriately followed through
Habituation: evidence that the therapist assisted
the client to identify and habituate to
spontaneous urges
8 Yes/no/or N/A Use of alternative cognitive techniques:
appropriately selected and applied, relevant to
therapy goals
Use of alternative behavioural techniques:
appropriately selected and applied, relevant to
therapy goals
9 0–10-Likert
scale
Overall rating of integrity Overall rating of integrity
10 Unlimited free
form text
Overall use of appropriate technique
(specifically, please comment on any area of the
session which may not have adhered to the
allocated therapeutic approach)
Overall use of appropriate technique
(specifically, please comment on any area of the
session which may not have adhered to the
allocated therapeutic approach)
Smith DP, Battersby MW, Harvey PW, et al. BMJ Open 2013;3:e003244. doi:10.1136/bmjopen-2013-003244 5
Trial protocol for gambling treatments
$25 at 6-month follow-up and $30 at 12-month follow-up.
For follow-up assessments, a relatively large time window
will be allowed to ensure maximum data collection and
questionnaires will be administered by post to limit the
burden to participants that may result from attending
appointments at the study-site during follow-up.42
Treatment drop-out
Treatment drop-out will be determined using two
general approaches.41 The ﬁrst approach will be based
on the therapists’ judgement of participant progress up
to the point of self-initiated termination. Second, attend-
ance at a prespeciﬁed number of sessions will also be
examined. A previous study involving SGTS participants
engaged in ET determined an appropriate cut-off
number of sessions for classiﬁcation as drop-out as three
or less, including the ﬁrst screening attendance.25
Similarly, in a randomised trial evaluating CT, partici-
pants who attended an initial study screening and two
treatment sessions or less were classiﬁed as drop-outs.29
The degree of concordance between these two classiﬁca-
tion methods for drop-outs will then be assessed and any
discrepancies will be resolved by discussion between the
clinical supervisors and therapists. The level of treatment
adherence for each participant will help inform second-
ary data analyses discussed in the following section.
Data analyses
The primary analysis will be an intent-to-treat (ITT) to
detect any statistically signiﬁcant differences in VGS
scores over time for the treatment and follow-up period
between cognitive and ET. To account for participant
attrition and lack of treatment adherence, the ITT ana-
lysis will be supplemented with an ‘as treated’ and ‘per
protocol’ analysis. The ‘as treated’ approach will be
useful for identifying associations between clusters of
participant characteristics and treatment outcomes from
an observational perspective. The ‘per protocol’ analysis
will enable an evaluation of treatment efﬁcacies in the
subsample of participants who adhere to their assigned
treatment protocol.43 Secondary measures will be ana-
lysed using the same approach as outlined above.
Generalised linear mixed models will be used for
repeated measures of primary and secondary continuous
and categorical outcomes. Preliminary models will assess
for Therapist and Therapist X Treatment Group effects
Table 3 Measurements
Measurements
Intervention period Maintenance period
Baseline
Sessions
2–12 Mid-treatment
End of
treatment 3 months 6 months 12 months
Demographics X
Duration of gambling
problem
X
AISS X
VGS X X X X X X
DSM-IV-TR X X X
Mechanisms of change
GRCS X X X X X X X
GUS X X X X X X X
Self-efficacy X X X X X X X
Problems caused by gambling
K10 X X X X X
WSAS X X X X X
AUDIT X X X X X
Gambling behaviours
Frequency* X X X X X X
Hours† X X X X X X
Amount ‡ X X X X X X
Treatment views
Confidence about
treatment
X§
Treatment is logical X§
Satisfied with treatment X
*Days/month in which gambling takes place.
†Time spent thinking about or engaged in the pursuit of gambling in previous month.
‡Expenditure in previous month.
§Session 2 only.
AISS, Arnett Inventory of Sensation Seeking Traits; AUDIT, Alcohol Use Disorders Identification Test; DSM-IV-TR, Diagnostic and Statistical
Manual of Mental Disorders, Text Revision (4th Edition); GRCS, Gambling-Related Cognitions Scale; GUS, Gambling Urge Scale; K10,
Kessler 10 Scale; VGS, Victorian Gambling Screen; WSAS, Work and Social Adjustment Scale.
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and will be included in the main analyses if statistically
signiﬁcant. Fixed effects in models will include the inter-
vention group, time in continuous form (intervention
period and maintenance effects) and interaction
between group and time. Random effects will be at the
study participant level and represent an upward or
downward shift in the outcome measure from an overall
regression line and the rate of change over time. Linear
combinations of regression coefﬁcients will be tested for
treatment group effect at the completion of the inter-
vention period and, for maintenance effects and esti-
mates, will be presented along with CI. Predicted
estimates of treatment outcomes at each time point will
be calculated using ﬁtted models of the data in order to
examine patterns of individual change within each
group. To interpret the effect sizes and precision for cat-
egorical outcomes, ORs and CI will be calculated.
To determine the mechanisms of therapeutic change
based on the intended effects of each treatment, a medi-
ation analysis will be conducted using mixed-effects
modelling. The analysis will follow the traditional
requirements for testing mediation: (1) testing for an
association between treatment condition (ET and CT)
and mediator (gambling urge or gambling-related cog-
nitions);(2) testing for an association between treatment
outcome variable (eg, gambling behaviours) and treat-
ment condition; (3) testing for an association between
the mediator and treatment outcome and(4) testing if
the effect of treatment condition on treatment outcome
is attenuated upon the addition of the mediator to the
model.44
In order to allow for an accurate critical appraisal of
the validity and applicability of results, the reporting of
this trial will comply with CONSORT (Consolidated
Standards of Reporting Trials) guidelines for non-
pharmacological treatment.45
Qualitative component
Despite the growing evidence base for cognitive and
behavioural therapies for problem gambling, the pro-
cesses and mechanisms of therapeutic change have not
been explored from the participant’s perspective and
experience. Therefore, following the treatment interven-
tion period, a subsample of participants will be invited
to take part in semistructured interviews to explore
therapeutic change for cognitive and exposure therap-
ies. One-on-one interviews with participants will be con-
ducted in person by the study research ofﬁcer for
approximately 1 h and audio recorded. To ensure the
capture of a range of individual experiences, purposeful
sampling will be used. Sampling will continue until the-
oretical saturation has been achieved, where no new or
relevant data are seen to emerge.46 All recordings will
be transcribed to a document, then veriﬁed for consist-
ency by the research ofﬁcer and uploaded to NVivo soft-
ware47 for data management. Interview transcripts will
be analysed using direct content analysis to report the
participant’s experiences at the semantic level around
speciﬁc and non-speciﬁc treatment effects. Initial coding
will be conducted by the research ofﬁcer and guided by
existing theory and research.48 A second researcher will
then cross-check the coding in order to reduce potential
subjectivity in the analysis.
DISCUSSION
This study will provide high quality data for therapeutic
beneﬁts of ET compared with CT in people seeking treat-
ment for problem gambling using EGMs. The outcome
data collected will cover the domains of gambling beha-
viours, problems caused by gambling and mechanisms of
change. Also, qualitative interviews will explore thera-
peutic change from the individual’s experience and be
examined in light of conclusions drawn from quantitative
models to better understand each treatment’s intended
effects. The ﬁndings are expected to guide consumers,
clinicians, policymakers and funders in the use of these
treatments for gambling disorders.
The design of this trial is guided by ethical considera-
tions, in line with the community service commitment of
SGTS. Therefore, a key strength of this study is that all
treatment-seeking problem gamblers meeting the eligi-
bility criteria will receive active treatment. Also, owing to
the broad study inclusion criteria, it is expected that a
signiﬁcant proportion of the sample will have comorbid
conditions (eg, anxiety, depression and substance
abuse10 49), which will enhance the external validity of
ﬁndings using an ITT design. A limitation of the design
is that there was no control group to account for non-
speciﬁc treatment effects; however, a reasonable assump-
tion is made that non-speciﬁc effects will be approxi-
mately similar between study groups due to the
analogous therapy structures, therapist background and
experience and therapeutic environment.
A further limitation of the study design is that outcome
data will be collected from self-report measures, and
therefore participants may overestimate the treatment
effects. As there is a high degree of uncertainty for differ-
ential treatment effects and blinding of participants to
the study hypothesis, the likelihood of bias in self-ratings
is expected to be minimised. Also, as this study will be
conducted at a single site, the ﬁndings will have some lim-
itations for inference to a wider population. On the other
hand, the beneﬁts of being a single-site study can include
more effective lines of communication and a more con-
sistent application of research protocol.
CONCLUSION
We have described the rationale and protocol for a
randomised clinical trial to investigate the treatment efﬁ-
cacy of ET compared with CT for people with a gam-
bling disorder in South Australia. The trial is funded,
due to a limited gambling treatment evidence base, to
inform a range of stakeholders on best practice. To our
knowledge, this is the ﬁrst randomised controlled trial to
compare treatments with theoretical underpinnings
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from each of the two important approaches in explain-
ing gambling disorders-cognitions (CT) and psychobio-
logical states (ET) in treatment-seeking problem
gamblers. The wide range of data collected in this trial
will provide high-quality evidence for these treatments
and contribute to the development of more optimal
combinations of cognitive and behavioural therapies.
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